65,437 trials
Pulmonary Disease
Primary: Number of Cases With Fever (Body Temperature Reach 38 Degree Celsius or Higher) — 0; 2 participants
Type 2 Diabetes Mellitus
Primary: Change in HbA1c From Baseline to Week 24 — -1.57; -0.90 percentage of total hemoglobin — p=<.0001
Tinea Pedis
Primary: Proportion of Subjects in Each Treatment Group With Therapeutic Success — 70; 95; 3 participants
Influenza
Primary: Number of Subjects Reporting Polymerase Chain Reaction (PCR)-Confirmed Influenza A and/or B Infection. — 274; 310 Participants
Postoperative Pain
Primary: Visual Analogue Scores (VAS) - Pain Scores Measured in mm (0-100) — 59.4; 30.2 units on a scale — p=0.001
Healthy
Primary: Percentage of Participants With a Significant Skin Event (Day 5 Cumulative) — 2.4 Percentage of participants
Meningitis · Meningococcal Meningitis · Meningococcal Infections
Primary: Number of Participants Reporting Solicited Injection Site or Systemic Reactions Following Vaccination With Either Menomune or Menactra Vaccine — 8; 33; 0; 1 Participants
Cardiovascular Diseases · Metabolic Syndrome X · Atherosclerosis
Primary: Change in Nitric Oxide Formation From Baseline to 3 Months — 27.6; 27.0; 31.4; 25.7 ng/mL
Relapsing Multiple Sclerosis
Primary: Immune Response 3 Weeks After Seasonal Influenza Vaccination — 53.3; 83.7 percentage of participants
Alzheimer's Disease
Primary: Number of Participants With Adverse Events (AEs) — 416; 259 Participants
Schizophrenia · Depression
Primary: Change From Baseline to Week 12 of Calgary Depression Scale for Schizophrenia (CDSS) Score. — 7.31; 5.53 Score on a scale
Asthma
Primary: Y=100([FEV1 at 1 Puffs-FEV1 at 4AM)/FEV1@4AM] Difference Period 2 Minus Period 1. — -15.4; 26.7 percentage of change from 4AM — p=0.026
Heart Failure · CHF
Primary: Time Required for the Pulmonary Artery Occlusion Pressure (PAOP) to be Maintained at a Value of Less Than or Equal to 18 mmHg for at Least Four Consecutive Hours (+/- 30…
Ankylosing Spondylitis
Primary: Percentage of Participants With a Clinical Response — 90.9; 9.1 percentage of participants
Type 2 Diabetes Mellitus
Primary: Change in HbA1c From Baseline to Week 26 — -1.55; -0.92; -1.23 percentage of total hemoglobin — p=<.0001